Cell Biology Group, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003 Barcelona, Spain.
J Cell Biol. 2011 Oct 17;195(2):307-22. doi: 10.1083/jcb.201104053. Epub 2011 Oct 10.
Repair of damaged tissue requires the coordinated action of inflammatory and tissue-specific cells to restore homeostasis, but the underlying regulatory mechanisms are poorly understood. In this paper, we report new roles for MKP-1 (mitogen-activated protein kinase [MAPK] phosphatase-1) in controlling macrophage phenotypic transitions necessary for appropriate muscle stem cell-dependent tissue repair. By restricting p38 MAPK activation, MKP-1 allows the early pro- to antiinflammatory macrophage transition and the later progression into a macrophage exhaustion-like state characterized by cytokine silencing, thereby permitting resolution of inflammation as tissue fully recovers. p38 hyperactivation in macrophages lacking MKP-1 induced the expression of microRNA-21 (miR-21), which in turn reduced PTEN (phosphatase and tensin homologue) levels, thereby extending AKT activation. In the absence of MKP-1, p38-induced AKT activity anticipated the acquisition of the antiinflammatory gene program and final cytokine silencing in macrophages, resulting in impaired tissue healing. Such defects were reversed by temporally controlled p38 inhibition. Conversely, miR-21-AKT interference altered homeostasis during tissue repair. This novel regulatory mechanism involving the appropriate balance of p38, MKP-1, miR-21, and AKT activities may have implications in chronic inflammatory degenerative diseases.
组织损伤的修复需要炎症细胞和组织特异性细胞的协调作用来恢复内稳态,但潜在的调控机制还知之甚少。在本文中,我们报道了 MKP-1(丝裂原活化蛋白激酶 [MAPK]磷酸酶-1)在控制巨噬细胞表型转变中的新作用,这些表型转变对于适当的肌肉干细胞依赖性组织修复是必需的。通过限制 p38 MAPK 的激活,MKP-1 允许早期的促炎到抗炎的巨噬细胞转化,以及随后进展为具有细胞因子沉默特征的巨噬细胞衰竭样状态,从而允许在组织完全恢复时炎症得到解决。缺乏 MKP-1 的巨噬细胞中 p38 的过度激活诱导 microRNA-21(miR-21)的表达,进而降低了磷酸酶和张力蛋白同源物(PTEN)的水平,从而延长了 AKT 的激活。在缺乏 MKP-1 的情况下,p38 诱导的 AKT 活性先于抗炎基因程序的获得和巨噬细胞中最终的细胞因子沉默,导致组织愈合受损。通过时间控制的 p38 抑制可以逆转这些缺陷。相反,miR-21-AKT 干扰改变了组织修复过程中的内稳态。这种涉及 p38、MKP-1、miR-21 和 AKT 活性适当平衡的新型调控机制可能对慢性炎症退行性疾病有影响。